4DMedical Limited
Tracked across 3 events · 26 articles · First seen Apr 20, 2026 · Last active Sep 14, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: 4DMedical Limited received TGA approval for its CT:VQ technology, enabling commercial deployment across Australia, which is a significant market for the company due to its high CT scanner density. This expands the company's market reach and potential revenue.
Jun 29, 2026 · 8 articles
Business
Virtual Investor Conferences, a proprietary investor conference series, announced on September 14, 2026 the agenda for its upcoming Life Sciences Virtual Investor Forum, scheduled for September 17, 2026 in New York. The online event is…
Impact: 4DMedical Limited is scheduled to present at 4:00 PM ET, closing the forum with an update on its medical imaging technology business.
Sep 14, 2026 · 12 articles
Business
Impact: 4DMedical Limited was one of the presenting companies at the Life Sciences Virtual Investor Forum.
Jun 26, 2026 · 6 articles
30
4DMedical Limited scheduled presentationLife Sciences Virtual...
ERGEN INTELLIGENCE
Track 4DMedical Limited live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard